SBC Medical Group Holdings Incorporated, a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, recently announced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management.
The initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately USD 800 billion in 2025 and expand to approximately USD 2 trillion by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. This strategy represents a natural extension of SBC Medical’s core business in Japan’s approximately USD 4 billion aesthetic healthcare market. While Japan’s domestic longevity market has already reached an estimated USD 34 billion, it remains in its early stages with no clear market leader, providing a significant opportunity for the Company to capture first-mover advantages. SBC Medical intends to use its existing clinic network and customer base in Japan to build recurring revenue streams and a differentiated, data-rich platform.
“Through aesthetic healthcare, we have helped many people build confidence in their appearance,” said Yoshiyuki Aikawa, CEO of SBC Medical. “What we have come to realize is that those who seek a youthful look are equally attuned to the signs of internal physical decline. SBC Wellness 2.0 was born from this insight. We are confident that only SBC Medical can deliver a standard of care that allows individuals to pursue ‘their best-ever self’ — across both appearance and physical function. We will first become the game changer in Japan’s domestic longevity market and then set our sights on the world.”
What is SBC Wellness 2.0?
SBC Wellness 2.0 focuses on prevention, physical performance, and overall health span rather than only treating disease. The service uses blood biomarkers, imaging, and AI tools to assess each customer’s condition and recommend personalized protocols that may include medical procedures, supplements, and lifestyle support. By integrating “youthful appearance” and “physical optimization,” SBC Medical establishes a new “performance medicine” category that goes beyond non-medical approaches like fitness and general supplements. The program follows a simple journey: measure key metrics, visualize biological age and risk, recommend a tailored plan, provide ongoing digital coaching, and track progress over time.
Competitive Advantages and Revenue Model
SBC Medical believes it is well-positioned in longevity, given its network of 283 clinics and about 6.5 million annual customer visits, which provide one of the largest aesthetic healthcare data sets in Japan. This large-scale data asset directly contributes to the advancement of proprietary AI models, establishing strong barriers to competitive entry. The Company operates on a medical platform that spans aesthetic healthcare procedures, and insurance‑covered care, and has long experience serving repeat, premium clients. Furthermore, SBC Medical’s expertise in high-value hospitality and user experience (UX) design, cultivated through its luxury clinic management, provides a meaningful advantage in meeting the needs of premium longevity customers.
SBC Medical expects to commercialize Wellness 2.0 through a mix of bundled programs sold to corporations as employee‑wellness benefits and higher‑value, self‑pay medical and aesthetic healthcare services sold directly to customers. The B2B model offers corporate clients a new form of human capital investment to enhance recruitment and reduce turnover, while providing the Company with an efficient growth model with low marketing costs. Management believes this combination of subscription‑like corporate contracts and discretionary medical services can support recurring revenue, higher retention, and improved unit economics over time.
